Merdad Parsey
Chief Tech/Sci/R&D Officer at GILEAD SCIENCES, INC.
Net worth: 6 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Kemble | M | 63 | 13 years | |
| Terry Rosen | M | 65 | 9 years | |
| David Happel | M | 62 | 2 years | |
| Juan Jaen | M | 66 | 9 years | |
| Jennifer Jarrett | F | 53 | 7 years | |
| Jeffrey Bluestone | M | 70 | 4 years | |
| Johanna Mercier | F | 54 | 5 years | |
| Deborah Telman | F | 59 | 2 years | |
| Christopher Fenimore | M | 54 | 21 years | |
| Elizabeth Rozek | F | 53 | 1 years | |
| Alexander Azoy | M | 48 | 4 years | |
| Nicole Lambert | F | 50 | 3 years | |
| Robert Goeltz | M | 51 | 4 years | |
| Andrew Dickinson | M | 54 | 8 years | |
| William Grossman | M | 54 | 5 years | |
| David Lacey | M | 71 | 4 years | |
| Sandra Horning | M | 75 | 4 years | |
| Antoni Ribas | M | 57 | 5 years | |
| Janice Chang | F | - |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | 10 years |
| Daniel O'Day | M | 59 | 5 years | |
| Beth Seidenberg | M | 67 | 17 years | |
| Kelly Kramer | F | 56 | 8 years | |
| Linda Higgins | M | 62 | 14 years | |
| Javier Rodriguez | M | 53 | 4 years | |
| Jacqueline Barton | M | 71 | 6 years | |
| Kathryn Falberg | F | 63 | 7 years | |
| Arthur Ryan | M | 81 | 21 years | |
| Yasunori Kaneko | M | 69 | 9 years | |
| Elizabeth Grammer | F | 60 | 3 years | |
| Richard Rodgers | M | 57 | 9 years | |
| Harish M. Manwani | M | 70 | 6 years | |
| Anthony Welters | M | 69 | 4 years | |
| Clarence Machado | M | 60 | 5 years | |
| Andrew Perlman | M | 76 | 4 years | |
| Sarah Miksinski | M | - | - | |
| Cindy Perettie | F | - | 1 years | |
| Dimitry Nuyten | M | - | 2 years | |
| Eric Matthews | M | - | 5 years | |
| Kathryn Owen | F | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Jyoti Mehra | F | 48 | 7 years | |
| Tomas Cihlar | M | 57 | - | |
| Francesco Marincola | M | - | - | |
| Duncan Jodrell | M | - | - | |
| Joydeep Ganguly | M | - | 5 years | |
| Stacey Ma | M | 54 | 2 years | |
| Adam Levy | M | - | - | |
| Flavius Martin | M | - | 3 years | |
| Dustin Haines | M | - | 2 years | |
| Johann Bono | M | - | - | |
| Holli Kolkey | M | - | - | |
| Steffen Roellinger | M | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Ursula Matulonis | F | - | - | |
| Steve Young | M | 55 | 8 years | |
| Ashleigh Koss | F | - | - | |
| Jacquie Ross | F | - | 3 years | |
| Jinzi Wu | M | 61 | 5 years | |
| Melissa Koomey | F | - | - | |
| C. Nicholson | M | 68 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | 7 years |
| Alexander Roderick MacKenzie | M | 65 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Anne-Marie O'Farrell | M | - | 11 years | |
| Sandra Patterson | F | 57 | 1 years | |
| Nathan Kaiser | M | - | - | |
| Brian Daniels | M | 65 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Takuko Yamada-Sawada | F | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | 10 years |
| Carolyn Tang | F | 45 | 7 years | |
| Jan Lundberg | M | 70 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Gaeton Biscardi | M | - | - | |
| Steven Gilman | M | 71 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| William Pao | M | 57 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Jonathan Yingling | M | 55 | 4 years | |
| Janet Dorling | F | 50 | 4 years | |
| Ted Love | M | 65 | - | |
| Eduardo Bruno Martins | M | 61 | 3 years | |
| Yvonne Gehring | F | - | 8 years | |
| Robert Cook | M | 65 | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brett Pletcher | M | 56 | 17 years | |
| Joseph Oriti | M | 44 | - | |
| Jason Barker | M | 54 | 1 years | |
| Michael Quigley | M | 42 | 1 years | |
| Anthony Rimac | M | 60 | 1 years | |
| Monica Tellado | F | 51 | 9 years | |
| Melissa C. Paoloni | M | - | 4 years | |
| Robert McDowell | M | 66 | 4 years | |
| Robin Washington | F | 60 | 11 years | |
| Stephen Brady | M | 54 | 3 years | |
| Richard Whitley | M | 78 | 13 years | |
| Kevin Lofton | M | 69 | 15 years | |
| Gordon Ringold | M | 73 | 14 years | |
| James Young | M | 71 | 13 years | |
| Douglas I. Buckley | M | - | 6 years | |
| Kartik Krishnan | M | - | 3 years | |
| Mark Genovese | M | - | 3 years | |
| Nick Giafis | M | - | 3 years | |
| Allan S. Wagman | M | - | 5 years | |
| Christopher Freeman | M | 50 | 1 years | |
| Mallory Morales | F | 40 | 1 years | |
| Patricia Carlos | F | - | 3 years | |
| Rekha Hemrajani | F | 54 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Merdad Parsey
- Personal Network
